GLP-3 Retatrutide - 20mg

Rt 20mg — Research Peptide

Retatrutide is a novel synthetic peptide engineered as a triple agonist at GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors. This multi-receptor targeting profile makes Retatrutide a uniquely powerful tool for studying the intersection of incretin biology, energy homeostasis, and metabolic signaling in preclinical research models.

Product Specifications

• Peptide: Retatrutide (GIP/GLP-1/Glucagon Triple Agonist)
• Quantity: 20mg per vial
• Purity: >99% (HPLC verified)
• Appearance: Lyophilized white powder
• Storage: Store at -20°C; stable for up to 24 months when lyophilized
• Reconstitution: Bacteriostatic water recommended

Research Applications

Retatrutide is studied in the context of metabolic disease, obesity biology, and multi-receptor agonism. Its simultaneous activation of GIP, GLP-1, and glucagon receptors provides researchers with a tool to investigate synergistic effects on insulin secretion, glucagon suppression, energy expenditure, and adipose tissue regulation in in vitro and in vivo preclinical models.

For Research Use Only. Not intended for human or veterinary use. Not for sale to individuals under 18 years of age.